p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
- 1 July 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (2), 208-215
- https://doi.org/10.1038/bjc.1996.339
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.Journal of Histochemistry & Cytochemistry, 1995
- Evidence for a p53‐independent pathway for upregulation of SDI1/CIP1/WAF1/P21 RNA in human cellsMolecular Carcinogenesis, 1994
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor statusVirchows Archiv, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Expression of the nuclear membrane protein statin in cycling cellsThe Journal of Pathology, 1993
- p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissueHistopathology, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991